U.S. flag

An official website of the United States government


Send to:

Choose Destination

Heinz bodies

MedGen UID:
Concept ID:
Cell Component
Synonyms: Bodies, Heinz; Heinz Bodies
SNOMED CT: Heinz body (42222008); Heinz-Ehrlich body (42222008)
HPO: HP:0020082


A type of erythrocyte inclusion composed of denatured hemoglobin. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVHeinz bodies

Conditions with this feature

Gluthathione peroxidase deficiency
MedGen UID:
Concept ID:
Disease or Syndrome
Several documented cases of glutathione peroxidase (GPX1; 138320) deficiency in association with hemolytic anemia have been reported. However, Paglia (1989) stated: 'To date, no defects in glutathione peroxidase have been unequivocally incriminated in the pathogenesis of hemolytic syndromes, although several instances of partial deficiency have been reported in patients with anemias of unknown etiology. This association may be coincidental, since there is a broad range of ethnic variation in the erythrocyte enzyme' (Beutler and Matsumoto, 1975).
Heinz body anemia
MedGen UID:
Concept ID:
Disease or Syndrome
This is a form of nonspherocytic hemolytic anemia of Dacie type I (in vitro autohemolysis is not corrected by added glucose). After splenectomy, which has little benefit, basophilic inclusions called Heinz bodies are demonstrable in the erythrocytes. Before splenectomy, diffuse or punctate basophilia may be evident. Most of these cases are probably instances of hemoglobinopathy. The hemoglobin demonstrates heat lability. Heinz bodies are observed also with the Ivemark syndrome (asplenia with cardiovascular anomalies; 208530).
Anemia, nonspherocytic hemolytic, due to G6PD deficiency
MedGen UID:
Concept ID:
Disease or Syndrome
G6PD deficiency is the most common genetic cause of chronic and drug-, food-, or infection-induced hemolytic anemia. G6PD catalyzes the first reaction in the pentose phosphate pathway, which is the only NADPH-generation process in mature red cells; therefore, defense against oxidative damage is dependent on G6PD. Most G6PD-deficient patients are asymptomatic throughout their life, but G6PD deficiency can be life-threatening. The most common clinical manifestations of G6PD deficiency are neonatal jaundice and acute hemolytic anemia, which in most patients is triggered by an exogenous agent, e.g., primaquine or fava beans. Acute hemolysis is characterized by fatigue, back pain, anemia, and jaundice. Increased unconjugated bilirubin, lactate dehydrogenase, and reticulocytosis are markers of the disorder. The striking similarity between the areas where G6PD deficiency is common and Plasmodium falciparum malaria (see 611162) is endemic provided evidence that G6PD deficiency confers resistance against malaria (summary by Cappellini and Fiorelli, 2008).

Professional guidelines


Yang XY, Qu Q, Yang TY, Chan WC, Chu JX, Chen Z, Ning AL, Liu FJ, Lin ZX, Zhou YL
Hemoglobin 1988;12(5-6):601-8. doi: 10.3109/03630268808991650. PMID: 3209402
Botella J, Traver JA, Sanz-Guajardo D, Torres MT, Sanjuan I, Zabala P
Proc Eur Dial Transplant Assoc 1977;14:192-9. PMID: 600956

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...